X

Xenon Pharmaceuticals
D

XENE

39.250
USD
0.22
(0.56%)
Market Closed
Volume
4,621
EPS
-4
Div Yield
-
P/E
-14
Market Cap
2,992,404,379
OverviewSignalsIdeasNews
Related Instruments
    ALNY
    ALNY
    1.73
    (0.65%)
    266.69 USD
    BIIB
    BIIB
    1.810
    (1.28%)
    142.750 USD
    B
    BLUE
    -0.31000
    (-3.79%)
    7.86000 USD
    GILD
    GILD
    0.070
    (0.08%)
    93.020 USD
    N
    NBIX
    0.840
    (0.58%)
    146.750 USD
    R
    RARE
    1.650
    (4.00%)
    42.950 USD
    S
    SRPT
    -0.920
    (-0.79%)
    116.020 USD
    VRTX
    VRTX
    0.08
    (0.02%)
    428.09 USD
    X
    XNCR
    0.250
    (1.22%)
    20.690 USD
    More
News

Title: Xenon Pharmaceuticals

Sector: Healthcare
Industry: Biotechnology
Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company committed to developing therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901, and XEN496 for Epilepsy, and Nav1.7 oral inhibitors for Pain. Geographically the activities are carried out throughout Canada.
Trading. Social. Simple.
FacebookTwitterYoutube
Company
Contact usAbout usTerms Of UsePrivacy PolicyCookies PolicyDisclaimerHelp Center
Social Network
The NetworkSignals NetworkIdeas NetworkBest Traders
Products
Risk CalculatorPip CalculatorAdvance Chart
Markets
Exchange RatesCommodities RatesCryptocurrencies RatesIndices RatesUS Stocks Rates
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.